Sign in

CIK 0000875320

  • Large accelerated filer

VERTEX PHARMACEUTICALS INC / MA

Sign in to watch
Ticker
VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
043039129
Phone
+1 617-341-6393
Business address
50 NORTHERN AVENUE, BOSTON, MA, 02210
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$14,681,876
in 2 filings, $14.7M under 10b5-1 plans

Net −$14,681,876. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-01-22 Sachdev Amit EVP Chief Patient & Ext Af Off Grant or award +3,883 70,998
2025-02-26 Sachdev Amit EVP Chief Patient & Ext Af Off Shares withheld for taxes −3,703 $479.61 $1.8M 68,490
2025-02-24 Sachdev Amit EVP Chief Patient & Ext Af Off Shares withheld for taxes −2,470 $483.28 $1.2M 72,193
2025-02-14 Sachdev Amit EVP Chief Patient & Ext Af Off Shares withheld for taxes −2,139 $463.46 $991K 74,663
2025-02-12 Sachdev Amit EVP Chief Patient & Ext Af Off Grant or award +6,211 76,802
2025-02-10 Sachdev Amit EVP Chief Patient & Ext Af Off Shares withheld for taxes −2,056 $467.98 $962K 70,591
2025-02-04 Sachdev Amit EVP Chief Patient & Ext Af Off Grant or award +8,210 65,533
2025-02-04 Sachdev Amit EVP Chief Patient & Ext Af Off Grant or award +7,114 72,647

Page 2 of 2 · 28 trades